Kalaris Therapeutics, Inc. (KLRS)

Profile

Full Name

Kalaris Therapeutics, Inc.

Ticker

NASDAQ: KLRS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 30, 2020

Indexes

Not included

Website

https://kalaristx.com

Employees

14

Key Details

Price

$5.47(0.37%)

Market Cap

$102.30M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$11.73(72.12% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.47
    KLRS price is $5.47

    30-Day Relative Volume

    1.34
    KLRS 30-day relative volume is 1.34

    Price Performance

    Price Most Recent Change

    +0.37%
    KLRS price was up +0.37% on Dec 2, 2025

    Price YTD Change

    -43.37%
    KLRS price is down -43.37% since January 1st

    Price 1-Year Change

    -55.21%
    KLRS price is down -55.21% year-on-year

    Price 3-Year Change

    -96.94%
    KLRS price is down -96.94% over the past 3 years

    Price Range

    Price All-Time High

    $1126.08
    KLRS price is currently -99.51% below its historical high of $1126.08

    Price 3-Year Low

    $2.14
    KLRS price is currently +155.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $102.30M
    KLRS market cap is $102.30 million

    Market Cap 3-Year Change

    -85.87%
    KLRS market cap is down -85.87% over the past 3 years

    Market Cap All-Time High

    $2.91B
    KLRS market cap is currently -96.48% below its historical high of $2.91 billion

    Market Cap Sector Percentile

    41.77%
    KLRS market cap is higher than 41.77% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +272.22%
    KLRS shares outstanding is up +272.22% year-on-year

    Shares Outstanding 3-Year Change

    +361.72%
    KLRS shares outstanding is up +361.72% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.86
    KLRS beta is 0.86

    200-day SMA

    $5.13
    KLRS price is currently +6.64% above its 200-day simple moving average

    50-day SMA

    $5.48
    KLRS price is currently -0.17% below its 50-day simple moving average

    14-Day RSI

    47.39
    KLRS 14-day relative strength index is 47.39

    Volume

    1.34
    KLRS 30-day relative volume is 1.34

    ATR

    $0.66
    KLRS average true range is $0.66

    10-day Historical Volatility

    133.49%
    KLRS 10-day historical volatility is 133.49%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    KLRS annual revenue is $0.00

    Revenue Analysts Estimate

    -
    KLRS annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    KLRS annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.31%
    KLRS annual revenue is higher than 28.31% of companies in Healthcare sector

    EPS

    EPS

    -$11.73
    KLRS annual earnings per share is -$11.73

    EPS Analysts Estimate

    -$3.70
    KLRS annual earnings per share is currently -217.13% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +72.12%
    KLRS annual earnings per share is up +72.12% year-on-year

    EPS Sector Percentile

    13.6%
    KLRS annual earnings per share is higher than 13.6% of companies in Healthcare sector

    Profit

    Gross Profit

    $0.00
    KLRS annual gross profit is $0.00

    Gross Margin

    -
    KLRS annual gross profit margin value is unknown

    Operating Profit

    -$55.26M
    KLRS annual operating income is -$55.26 million

    Operating Margin

    -
    KLRS annual operating profit margin value is unknown

    Net Income

    -$58.77M
    KLRS annual net profit is -$58.77 million

    Net Margin

    -
    KLRS annual net profit margin value is unknown

    Expenses

    Total Expenses

    $58.77M
    KLRS annual total expenses is $58.77 million

    Operating Expenses

    $55.26M
    KLRS annual total operating expenses is $55.26 million

    Cost Of Goods Sold

    $0.00
    KLRS annual cost of goods sold is $0.00

    Selling, General & Administrative Expenses

    $0.00
    KLRS annual SG&A is $0.00

    Depreciation & Amortization

    $0.00
    KLRS annual D&A is $0.00

    Interest Expense

    $0.00
    KLRS annual interest expense is $0.00

    Income Tax

    $0.00
    KLRS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$55.26M
    KLRS annual earnings before interest & taxes is -$55.26 million

    EBITDA

    -$55.26M
    KLRS annual EBITDA is -$55.26 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $118.55M
    KLRS annual total assets is $118.55 million

    Non Current Assets

    $0.00
    KLRS annual long term assets is $0.00

    Current Assets

    $118.55M
    KLRS annual total current assets is $118.55 million

    Cash and Cash Equivalents

    $118.29M
    KLRS annual cash & cash equivalents is $118.29 million

    Accounts Receivable

    -
    KLRS annual accounts receivable value is unknown

    Inventory

    $0.00
    KLRS annual inventory is $0.00

    Liabilities

    Total Liabilities

    $5.24M
    KLRS annual total liabilities is $5.24 million

    Long Term Liabilities

    $0.00
    KLRS annual total long term liabilities is $0.00

    Current Liabilities

    $5.24M
    KLRS annual current liabilities is $5.24 million

    Accounts Payable

    $247.00K
    KLRS annual accounts payable is $247.00 thousand

    Debt

    Total Debt

    $0.00
    KLRS annual total debt is $0.00

    Total Debt 1-Year Change

    -100%
    KLRS annual total debt is down -100% year-on-year

    Long Term Debt

    $0.00
    KLRS annual long term debt is $0.00

    Short Term Debt

    $0.00
    KLRS annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    $113.31M
    KLRS annual stockholders equity is $113.31 million

    Book Value

    $113.31M
    KLRS annual book value is $113.31 million

    Retained Earnings

    -$714.96M
    KLRS annual retained earnings is -$714.96 million

    Working Capital

    $113.31M
    KLRS annual working capital is $113.31 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$67.70M
    KLRS annual cash from operations is -$67.70 million

    Cash From Operations 1-Year Change

    +45.6%
    KLRS annual cash from operations is up +45.6% year-on-year

    Cash From Investing

    $95.00M
    KLRS annual cash from investing is $95.00 million

    Cash From Investing 1-Year Change

    +150.1%
    KLRS annual cash from investing is up +150.1% year-on-year

    Cash From Financing

    $21.00K
    KLRS annual cash from financing is $21.00 thousand

    Cash From Financing 1-Year Change

    -99.97%
    KLRS annual cash from financing is down -99.97% year-on-year

    CAPEX

    CAPEX

    $0.00
    KLRS annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    KLRS annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$67.70M
    KLRS annual free cash flow is -$67.70 million

    Free Cash Flow 1-Year Change

    +45.6%
    KLRS annual free cash flow is up +45.6% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    KLRS annual gross profit margin value is unknown

    Operating Margin

    -
    KLRS annual operating profit margin value is unknown

    Net Margin

    -
    KLRS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -38.00%
    KLRS annual return on assets is -38.00%

    ROE

    -45.37%
    KLRS annual return on equity is -45.37%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    KLRS price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    KLRS price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    2.44
    KLRS price to book ratio is 2.44

    PB Ratio Sector Percentile

    56.32%
    KLRS price to book ratio is higher than 56.32% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    KLRS price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    KLRS price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $26.85M
    KLRS enterprise value is $26.85 million

    Enterprise Value Sector Percentile

    30.54%
    KLRS enterprise value is higher than 30.54% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.49
    KLRS EV/EBITDA is -0.49

    EV/EBITDA Sector Percentile

    52.46%
    KLRS EV/EBITDA is higher than 52.46% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    22.63
    KLRS annual current ratio is 22.63

    Quick Ratio

    22.63
    KLRS annual quick ratio is 22.63

    Leverage

    Debt To Equity

    0.00
    KLRS annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    KLRS annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    KLRS piotroski f-score value is unknown

    Altman Z-Score

    2.88
    KLRS altman z-score is 2.88

    Analyst ratings

    Recent major analysts updates

    Nov 3, 25 Citizens
    Market Outperform
    Sep 3, 25 Raymond James
    Strong Buy
    Apr 8, 25 William Blair
    Outperform

    Institutional Ownership

    Screeners with KLRS included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Kalaris Therapeutics, Inc.?
    • Does Kalaris Therapeutics, Inc. pay dividends?
    • What sector is Kalaris Therapeutics, Inc. in?
    • What industry is Kalaris Therapeutics, Inc. in?
    • What country is Kalaris Therapeutics, Inc. based in?
    • When did Kalaris Therapeutics, Inc. go public?
    • Is Kalaris Therapeutics, Inc. in the S&P 500?
    • Is Kalaris Therapeutics, Inc. in the NASDAQ 100?
    • Is Kalaris Therapeutics, Inc. in the Dow Jones?
    • When was Kalaris Therapeutics, Inc.'s last earnings report?
    • When does Kalaris Therapeutics, Inc. report earnings?

    What is the ticker symbol for Kalaris Therapeutics, Inc.?

    The ticker symbol for Kalaris Therapeutics, Inc. is NASDAQ:KLRS

    Does Kalaris Therapeutics, Inc. pay dividends?

    No, Kalaris Therapeutics, Inc. does not pay dividends

    What sector is Kalaris Therapeutics, Inc. in?

    Kalaris Therapeutics, Inc. is in the Healthcare sector

    What industry is Kalaris Therapeutics, Inc. in?

    Kalaris Therapeutics, Inc. is in the Biotechnology industry

    What country is Kalaris Therapeutics, Inc. based in?

    Kalaris Therapeutics, Inc. is headquartered in United States

    When did Kalaris Therapeutics, Inc. go public?

    Kalaris Therapeutics, Inc.'s initial public offering (IPO) was on July 30, 2020

    Is Kalaris Therapeutics, Inc. in the S&P 500?

    No, Kalaris Therapeutics, Inc. is not included in the S&P 500 index

    Is Kalaris Therapeutics, Inc. in the NASDAQ 100?

    No, Kalaris Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Kalaris Therapeutics, Inc. in the Dow Jones?

    No, Kalaris Therapeutics, Inc. is not included in the Dow Jones index

    When was Kalaris Therapeutics, Inc.'s last earnings report?

    Kalaris Therapeutics, Inc.'s most recent earnings report was on August 7, 2025

    When does Kalaris Therapeutics, Inc. report earnings?

    The date for Kalaris Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page